Goldman Sachs: Solomon makes his biggest acquisition yet

Plus, a US biotech company takes a bold step in an international regulatory battle, and Jay Clayton takes the crypto revolving door

Weight-loss drugs reduce risk of Alzheimer’s, large study shows